THAR
Canton Strategic Holdings, Inc.
Key Financials
Operating Income
$-20106066
↓ 61.7%
Net Income
$-35916250
↓ 194.5%
EPS (Diluted)
$-1.12
↑ 88.1%
Total Assets
$519.1M
↑ 13849.5%
Cash & Equivalents
$10.9M
↑ 68.0%
Total Liabilities
$121.2M
↑ 4921.6%
Shareholders' Equity
$397.9M
↑ 30330.8%
Operating Cash Flow
$-16128316.00
↓ 47.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/13/2026 | View on SEC |
| SCHEDULE 13G/A | 5/11/2026 | View on SEC |
| D | 4/15/2026 | View on SEC |
| D | 4/15/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| S-8 | 3/11/2026 | View on SEC |
| 8-K | 3/3/2026 | View on SEC |
| 424B5 | 3/3/2026 | View on SEC |
| 8-K | 3/3/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | THAR |
| Company Name | Canton Strategic Holdings, Inc. |
| CIK | 1861657 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 302-743-2995 |